Labtec GmbH: Clinical Trials

2 trials sponsored by Labtec GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Withdrawn 1

Follow Labtec GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
Acyclovir patch, Placebo patch - Herpes Labialis
Phase 1CompletedGlaxoSmithKline602012-07-012014-07-16
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
Sufentanil, Sustained Release Morphine Sulfate - Chronic Pain
Phase 2WithdrawnLabtec GmbH2010-01-012015-09-15

Conditions studied

Chronic Pain (1)  ·  Herpes Labialis (1)  ·  Neoplasms (1)  ·  Pain (1)

Interventions

Sufentanil (1)

Countries

Germany (1)

Results publications

PMID 33913104